NCT05509855View on ClinicalTrials.gov

A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007

Enrolling by invitationOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

August 22, 2022

Primary Completion Date

July 1, 2037

Study Completion Date

July 1, 2037

Conditions
T-cell Acute Lymphoblastic LeukemiaT-cell Lymphoblastic Lymphoma
Interventions
GENETIC

Genetic: WU-CART-007

No study drug is administered in this study. Patients who have received WU-CART-007 will be enrolled in this study for Long Term Safety and Efficacy

Trial Locations (5)

19104

Children's Hospital of Philadelphia, Philadelphia

63110

Washington University, St Louis

90027

Childrens Hospital LA, Los Angeles

91010

City of Hope, Duarte

Unknown

Peter MacCullam Cancer Center, Melbourne

All Listed Sponsors
lead

Wugen, Inc.

INDUSTRY